3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Breast Neoplasms
19
Glioblastoma
18
Lung Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
14
Glioma
12
Rectal Neoplasms
11
Neoplasms
11
Head and Neck Neoplasms
11
Oropharyngeal Neoplasms
9
Esophageal Neoplasms
8
Astrocytoma
8
Uterine Cervical Neoplasms
7
Sarcoma
7
Neoplasm Metastasis
7
Colorectal Neoplasms
7
Brain Neoplasms
7
Urinary Bladder Neoplasms
6
Small Cell Lung Carcinoma
6
Esophageal Squamous Cell Carcinoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
5
Gliosarcoma
5
Carcinoma, Squamous Cell
5
Carcinoma, Hepatocellular
5
Carcinoma
5
Burkitt Lymphoma
5
Adenocarcinoma of Lung
5
Stomach Neoplasms
4
Interventions
gallium Ga 68 dotatate
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Nivolumab
1
Eflornithine
1
Drug Therapy
1
CLR1404
1
Blood Specimen Collection
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Radiotherapy
×
90 days
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled